Guidelines for the treatment of Alzheimer's disease from the Italian Association of Psychogeriatrics

Drugs & Aging
Carlo CaltagironeItalian Association of Psychogeriatrics

Abstract

A committee of experts from the Italian Association of Psychogeriatrics compiled the following report, which was then approved by a Steering Committee (comprising 20 specialists in neurology, psychiatry or geriatrics) from the Association and by two Alzheimer associations representing patients and families: the Italian Association for Alzheimer's Disease and the Italian Federation for Alzheimer's Disease. The report is based on a comprehensive review of the scientific literature on the treatment of Alzheimer's disease, discusses methodological aspects of dementia management, and details the limitations of current therapies. These guidelines are, in general, consistent with the principles of evidence-based medicine; however, for some controversial or poorly investigated issues, the guidelines integrate scientific evidence with experience and opinions from experts working in the clinical setting. In particular, the clinical experience of experts has been used to define recommendations for starting and interrupting pharmacotherapy, and to critically review evidence about the efficacy of non-pharmacological interventions. The principal pharmacotherapeutic interventions covered in the guidelines are acetylcholinesterase inhibitors (...Continue Reading

References

May 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·R T Woods
Dec 1, 1991·Journal of the American Geriatrics Society·L BergK Maslow
Apr 1, 1990·The Gerontologist·D HolmesR Vickers
Aug 1, 1987·The British Journal of Psychiatry : the Journal of Mental Science·S BainesK Ehlert
Jan 1, 1986·Progress in Neuro-psychopharmacology & Biological Psychiatry·W W FleischhackerH Schubert
Mar 1, 1987·The British Journal of Psychiatry : the Journal of Mental Science·T J Van der CammenA N Exton-Smith
Sep 1, 1983·The British Journal of Medical Psychology·G G WallisP Higginbotham
Jan 1, 1981·The British Journal of Psychiatry : the Journal of Mental Science·I G HanleyW D Boyd
Dec 1, 1995·Journal of the American Geriatrics Society·T T Perls, M Herget
Jun 1, 1994·Journal of the American Geriatrics Society·L VolicerS Karon
Oct 1, 1994·Archives of Psychiatric Nursing·K Robinson, K Yates
Apr 25, 1994·Archives of Internal Medicine·S BrooksJ R Kues
Apr 1, 1993·Perceptual and Motor Skills·T R Lord, J E Garner
Mar 1, 1996·Journal of the American Geriatrics Society·H WhiteG Fillenbaum
Oct 1, 1996·Journal of the American Dietetic Association·A A SpindlerJ W Ramsdell
Jan 1, 1996·The Journal of Neuropsychiatry and Clinical Neurosciences·G PetraccaS E Starkstein
Nov 1, 1996·Journal of the American Geriatrics Society·S FranzoniM Trabucchi
Mar 1, 1997·Alzheimer Disease and Associated Disorders·A BianchettiM Trabucchi
Jan 1, 1997·Journal of Geriatric Psychiatry and Neurology·G J WalstraH van Crevel
Oct 29, 1997·JAMA : the Journal of the American Medical Association·P L Le BarsA F Schatzberg
Jan 20, 1998·The American Journal of Psychiatry·P N TariotC Irvine
Feb 7, 1998·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·S L Rogers, L T Friedhoff
Jun 27, 1998·JAMA : the Journal of the American Medical Association·M D GrantJ A Brody
Sep 3, 1998·The Gerontologist·G BellelliM Trabucchi
Apr 24, 1999·BMJ : British Medical Journal·T Bayer
Apr 24, 1999·BMJ : British Medical Journal·A Berger
May 15, 1999·Dementia and Geriatric Cognitive Disorders·A BurnsL T Friedhoff
Aug 14, 1999·Journal of Geriatric Psychiatry and Neurology·M Trabucchi
Sep 18, 1999·International Journal of Geriatric Psychiatry·D LogiudiceL Flicker
Jan 20, 2000·The New England Journal of Medicine·M R Gillick
May 4, 2000·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·S L RogersJ R Ieni

❮ Previous
Next ❯

Citations

Aug 11, 2007·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·C A DefantiUNKNOWN Bioethics and Palliative Care in Neurology Study Group of the Italian Society of Neurology
Apr 16, 2010·International Journal of Technology Assessment in Health Care·Paulo Dornelles PiconMárcia L F Chaves
Jul 4, 2007·Primary Care Companion to the Journal of Clinical Psychiatry·David S Geldmacher
Jun 29, 2011·Future Medicinal Chemistry·Vinicius Barreto da SilvaCarlos Henrique Tomich de Paula da Silva
Dec 5, 2012·The Journal of Nutrition, Health & Aging·A CherubiniM Trabucchi
Feb 4, 2010·The Journal of Nutrition, Health & Aging·M TsolakiUNKNOWN European Alzheimer Disease Consortium
Jun 6, 2008·Alzheimer Disease and Associated Disorders·Alfredo RaglioMarco Trabucchi
Sep 16, 2008·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Amos D Korczyn
Mar 4, 2011·International Journal of Geriatric Psychiatry·E VasseE Moniz-Cook
May 3, 2007·Expert Opinion on Pharmacotherapy·Ben Seltzer
Nov 20, 2010·Journal of Psychopharmacology·John T O'BrienUNKNOWN BAP Dementia Consensus Group
Feb 3, 2007·American Journal of Alzheimer's Disease and Other Dementias·Perla Werner
Jan 17, 2008·Dementia and Geriatric Cognitive Disorders·Luc Pieter De VreeseUNKNOWN Multicentre Study Group
Jul 1, 2007·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Krista L Lanctôt, Nathan Herrmann
Dec 5, 2009·Aging Clinical and Experimental Research·Elena SinforianiGiuseppe Nappi
Jun 17, 2020·Journal of Alzheimer's Disease : JAD·Bernadeth Lyn C PiamonteVeeda Michelle M Anlacan
Jun 1, 2017·Frontiers in Psychology·Siv K A PedersenStefan Sütterlin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.